Press Releases Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
4.06 ^USD	-2.64%		-11.74%	-18.96%

May. 16	Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating	MT
May. 15	Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	May. 23	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	May. 16	PR
Abeona Therapeutics: Q1 Earnings Snapshot	May. 15	AQ
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress	May. 15	AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	May. 07	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	May. 06	PR
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants	May. 06	AQ
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants	May. 03	AQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors	May. 02	BU
Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors	May. 01	BU
The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors	Apr. 29	BU
Abeona Therapeutics Provides Regulatory Update on Pz-cel	Apr. 22	AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Apr. 01	AQ
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections	Mar. 18	AQ
Abeona Therapeutics Announces New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	Mar. 06	AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Mar. 05	AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Feb. 01	AQ
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)	Feb. 01	AQ
Abeona Therapeutics Announces $50 Million Credit Facility	Jan. 08	AQ
Abeona Therapeutics Announces New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	Dec. 18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Press Releases

Filters